| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on March 3, 2004
Accepted on July 26, 2004
From Third Department of Internal Medicine (H.Y., N.S., H.T., Y.J., T.K.) and Department of Laboratory Medicine (M.I., A.H., M.T.), Yamagata University School of Medicine, Yamagata, Japan.
* To whom correspondence should be addressed. E-mail: migarasi{at}med.id.yamagata-u.ac.jp.
Objective--We investigated the regulation of p38 mitogen-activated protein kinase by platelet-derived growth factor (PDGF)-BB and its biological effects in cultured normal and diabetic rat vascular smooth muscle cells (VSMCs).
Methods and Results--VSMC growth from diabetic rats was faster than that from normal rats. The expression of the PDGF
-receptor in diabetic VSMCs was significantly elevated compared with that in normal cells, and PDGF-BB-induced p38 phosphorylation in diabetic cells was more enhanced via MAP kinase kinase (MKK) 3/6. The level of PKC activity in diabetic cells increased more than that in normal cells with or without PDGF-BB. Although protein kinase C (PKC)-
II and PKC-
were activated by diabetes, PDGF-BB could further enhance the level of PKC-
alone. PDGF-BB-induced cell migration was more elevated in diabetic VSMCs, and the increase was significantly inhibited by SB-203580, rottlerin, and antisense oligodeoxynucleotides for PKC-
. PDGF-BB-induced p38 phosphorylation also regulated cell growth, cyclooxygenase-2 levels, and arachidonic acid release, but not apoptosis. These levels were more elevated in diabetic cells, which were inhibited by SB-203580.
Conclusions--Our study established that PDGF-BB phosphorylated p38 via PKC-
and the subsequent MKK 3/6, leading to cell growth regulation and the progression of a chronic inflammatory process in diabetic VSMCs.
This article has been cited by other articles:
![]() |
H. A. Madi, K. Riches, P. Warburton, D. J. O'Regan, N. A. Turner, and K. E. Porter Inherent differences in morphology, proliferation, and migration in saphenous vein smooth muscle cells cultured from nondiabetic and Type 2 diabetic patients Am J Physiol Cell Physiol, November 1, 2009; 297(5): C1307 - C1317. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Zheng, M. Han, M. Bernier, X.-h. Zhang, F. Meng, S.-b. Miao, M. He, X.-m. Zhao, and J.-k. Wen Kruppel-like Factor 4 Inhibits Proliferation by Platelet-derived Growth Factor Receptor {beta}-mediated, Not by Retinoic Acid Receptor {alpha}-mediated, Phosphatidylinositol 3-Kinase and ERK Signaling in Vascular Smooth Muscle Cells J. Biol. Chem., August 21, 2009; 284(34): 22773 - 22785. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ishizawa, N. Dorjsuren, Y. Izawa-Ishizawa, R. Sugimoto, Y. Ikeda, Y. Kihira, K. Kawazoe, S. Tomita, K. Tsuchiya, K. Minakuchi, et al. Inhibitory effects of adiponectin on platelet-derived growth factor-induced mesangial cell migration J. Endocrinol., August 1, 2009; 202(2): 309 - 316. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Cavet, E. M. Smolock, O. H. Ozturk, C. World, J. Pang, A. Konishi, and B. C. Berk Gas6-Axl Receptor Signaling Is Regulated by Glucose in Vascular Smooth Muscle Cells Arterioscler Thromb Vasc Biol, May 1, 2008; 28(5): 886 - 891. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Louis, A. Kakou, V. Regnault, C. Labat, A. Bressenot, J. Gao-Li, H. Gardner, S. N. Thornton, P. Challande, Z. Li, et al. Role of {alpha}1beta1-integrin in arterial stiffness and angiotensin-induced arterial wall hypertrophy in mice Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2597 - H2604. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-K. Lee, H. M. Lee, H. J. Kim, H.-J. Park, K.-J. Won, H. Y. Roh, W. S. Choi, B. H. Jeon, T.-K. Park, and B. Kim Syk contributes to PDGF-BB-mediated migration of rat aortic smooth muscle cells via MAPK pathways Cardiovasc Res, April 1, 2007; 74(1): 159 - 168. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. F. Collins, Y. Xiong, E. G. Lupo Jr., H.-Y. Liu, and W. Cao p38 Mitogen-activated Protein Kinase Mediates Free Fatty Acid-induced Gluconeogenesis in Hepatocytes J. Biol. Chem., August 25, 2006; 281(34): 24336 - 24344. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |